Darrick Carter

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

NPJ vaccines

Science translational medicine

Journal of immunology (Baltimore, Md. : 1950)

Clinical & translational immunology

University of Washington

Oregon Health and Science University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Washington Jun 01 2014

United States

Affiliate Professor :: Medical Genetics

Compliment Corp. Aug 01 2009

United States

CEO :: Research

Infectious Disease Research Institute Jan 01 2005

United States

Vice President :: Adjuvants

PAI Life Sciences Inc. Apr 01 2004

United States

CEO :: Research

Education History

Oregon Health and Science University Oct 01 1993 - Oct 01 1998

United States

PHD :: Biochemistry

Oregon State University Oct 01 1990 - Jun 30 1993

United States

BSC :: Biochemistry

Publications

Steven G Reed, Darrick Carter
Make it a combo. Science translational medicine 16 (758) (2024)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
Nathan M Ryan, Jessica A Hess, Erica J Robertson, Nancy Tricoche, Cheri Turner, Jenn Davis, Nikolai Petrovsky, Melissa Ferguson, William J Rinaldi, Valerie M Wong, Ayako Shimada, Bin Zhan, Maria-Elena Bottazzi, Benjamin L Makepeace, Sean A Gray, Darrick Carter, Sara Lustigman, David Abraham
Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates. Vaccines 11 (7) (2023)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
Jesse H Erasmus, Amit P Khandhar, Megan Ashley O'Connor, Alexandra C Walls, Emily A Hemann, Patience Murapa, Jacob Archer, Shanna Leventhal, James T Fuller, Thomas B Lewis, Kevin E Draves, Samantha Randall, Kathryn A Guerriero, Malcolm S Duthie, Darrick Carter, Steven G Reed, David W Hawman, Heinrich Feldmann, Michael Gale, David Veesler, Peter Berglund, Deborah Heydenburg Fuller
An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Science translational medicine 12 (555) (2020)
Amit P Khandhar, Hong Liang, Adrian C Simpson, Steven G Reed, Darrick Carter, Christopher B Fox, Mark T Orr
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cells. Nanoscale 12 (4) (2020)
Ragan Pitner, Jiho Kim, Jenn Davis-Bergthold, Cheri Turner, Emilie Vassal-Stermann, Hongjie Wang, Jaclyn Adams, Lauren Carter, Jeffrey A Ahlgren, Pascal Fender, André Lieber, Darrick Carter, Sean A Gray
Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy. Scientific reports 9 (1) (2019)
Emilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, Michelle Archer, Nicholas D Rintala, Ryan Kramer, Darrick Carter, Christopher B Fox, Mark T Orr
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 201 (1) (2018)
Darrick Carter, Neal van Hoeven, Susan L Baldwin, Yotam Levin, Efrat Kochba, Al Magill, Nathalie Charland, Nathalie Landry, Khin Nu, Aude Frevol, Jill Ashman, Zachary K Sagawa, Anna Marie Beckmann, Steven G Reed
The adjuvant GLA-AF enhances human intradermal vaccine responses. Science advances 4 (9) (2018)
Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, Senthil Kumar Raman, Christopher P Karch, Craig W Roberts, David E Lanar, Steve Reed, Chris Fox, Darrick Carter, Jeff Alexander, Alessandro Sette, John Sidney, Hernan Lorenzi, Ian J Begeman, Peter Burkhard, Rima McLeod
Protein nanovaccine confers robust immunity against Toxoplasma. NPJ vaccines 2 (2017)
Darrick Carter, Christopher B Fox, Tracey A Day, Jeffrey A Guderian, Hong Liang, Tom Rolf, Julie Vergara, Zachary K Sagawa, Greg Ireton, Mark T Orr, Anthony Desbien, Malcolm S Duthie, Rhea N Coler, Steven G Reed
A structure-function approach to optimizing TLR4 ligands for human vaccines. Clinical & translational immunology 5 (11) (2016)
Anthony L Desbien, Natasha Dubois Cauwelaert, Steven J Reed, Hilton R Bailor, Hong Liang, Darrick Carter, Malcolm S Duthie, Christopher B Fox, Steven G Reed, Mark T Orr
IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants. Journal of immunology (Baltimore, Md. : 1950) 197 (11) (2016)

Darrick Carter.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Darrick Carter